Literature DB >> 15540509

Epidermal growth factor receptor (EGFR) gene Bsr I polymorphism is associated with systemic lupus erythematosus.

C-M Huang1, C-H Tsai, C-L Chen, C-P Chang, C-C Lai, F-J Tsai.   

Abstract

The purpose of this study was to determine if epidermal growth factor receptor (EGFR) gene polymorphism was a marker of susceptibility to or severity of Chinese patients with systemic lupus erythematosus (SLE) in Taiwan. The study included 119 Chinese patients with SLE. One hundred unrelated healthy individuals living in central Taiwan served as control subjects. Polymorphisms of the EGFR Bsr I gene were typed from genomic DNA. The genotypes, allelic frequencies and carriage rates were compared between SLE patients and control subjects. The relationship between allelic frequencies and clinical manifestations of SLE was evaluated. For the genotype of EGFR gene Bsr I polymorphism, there was statistically significant differences between the SLE and control groups (chi-squared test, P = 0.009, chi2 = 9.21). In addition, there was significant association between the two groups in allelic frequency of the T allele (P = 0.02, chi2 = 5.27). However, we did not detect any association between EGFR genotype and clinical or laboratory profiles in SLE patients. The results suggest that the EGFR gene Bsr I polymorphism is related to SLE.

Entities:  

Mesh:

Year:  2004        PMID: 15540509     DOI: 10.1191/0961203304lu1081oa

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  7 in total

Review 1.  The serine/threonine protein phosphatase 2A controls autoimmunity.

Authors:  Amir Sharabi; Isaac R Kasper; George C Tsokos
Journal:  Clin Immunol       Date:  2017-07-21       Impact factor: 3.969

2.  Association of rheumatoid arthritis risk with EGFR genetic polymorphisms in Taiwan's Han Chinese population.

Authors:  Sui-Foon Lo; Lei Wan; Hsiu-Chen Lin; Chung-Ming Huang; Shih-Yin Chen; Su-Ching Liu; Fuu-Jen Tsai
Journal:  Rheumatol Int       Date:  2011-05-21       Impact factor: 2.631

3.  Molecular imaging of active mutant L858R EGF receptor (EGFR) kinase-expressing nonsmall cell lung carcinomas using PET/CT.

Authors:  Hsin Hsien Yeh; Kazuma Ogawa; Julius Balatoni; Uday Mukhapadhyay; Asutosh Pal; Carlos Gonzalez-Lepera; Aleksandr Shavrin; Suren Soghomonyan; Leo Flores; Daniel Young; Andrei Y Volgin; Amer M Najjar; Victor Krasnykh; William Tong; Mian M Alauddin; Juri G Gelovani
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

4.  Molecular Taxonomy of Systemic Lupus Erythematosus Through Data-Driven Patient Stratification: Molecular Endotypes and Cluster-Tailored Drugs.

Authors:  Panagiotis Garantziotis; Dimitrios Nikolakis; Stavros Doumas; Eleni Frangou; George Sentis; Anastasia Filia; Antonis Fanouriakis; George Bertsias; Dimitrios T Boumpas
Journal:  Front Immunol       Date:  2022-05-09       Impact factor: 8.786

5.  Association of Polymorphisms in Connective Tissue Growth Factor and Epidermal Growth Factor Receptor Genes With Human Longevity.

Authors:  Timothy A Donlon; Brian J Morris; Qimei He; Randi Chen; Kamal H Masaki; Richard C Allsopp; D Craig Willcox; Gregory J Tranah; Neeta Parimi; Daniel S Evans; Friederike Flachsbart; Almut Nebel; Duk-Hwan Kim; Joobae Park; Bradley J Willcox
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-08-01       Impact factor: 6.053

6.  Association between EGF and EGFR Gene Polymorphisms and Susceptibility to Alopecia Areata in the Korean Population.

Authors:  Yong-Yon Won; Sik Haw; Joo-Ho Chung; Bark-Lynn Lew; Woo-Young Sim
Journal:  Ann Dermatol       Date:  2019-07-01       Impact factor: 1.444

7.  A Network Pharmacology and Molecular Docking Strategy to Explore Potential Targets and Mechanisms Underlying the Effect of Curcumin on Osteonecrosis of the Femoral Head in Systemic Lupus Erythematosus.

Authors:  Pan Kang; Zhiming Wu; Yue Zhong; Zihao Wang; Chi Zhou; Shaochuan Huo; Hai Guo; Songtao Li; Kun Xu; Lingyun Liu; Shuai Chen; Hongyu Tang; Haibin Wang
Journal:  Biomed Res Int       Date:  2021-09-13       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.